The synthetic compound NO-1886 is a lipoprotein lipase activator that has been proven to be highly effective in lowering plasma triglycerides and elevating high-density lipoprotein cholesterol. It was found that NO-1886 also had a plasma glucose-reducing action in high-fat/high-sucrose diet-induced diabetic rabbits. In the currentstudy, the effects of NO-1886 on the morphology of adipocytes, plasma levels of tumor necrosis factor-α (TNF-α) and free fatty acids (FFA) in miniature pigs fed a high fat/high su...